Viemed Healthcare, Inc.
VMD
$8.71
-$0.51-5.53%
NASDAQ
| 12/31/2025 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 5.93% | 14.05% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 5.93% | 14.05% | |||
| Cost of Revenue | 4.94% | 16.12% | |||
| Gross Profit | 6.67% | 12.56% | |||
| SG&A Expenses | 3.44% | 6.95% | |||
| Depreciation & Amortization | -2.52% | 12.46% | |||
| Other Operating Expenses | -38.64% | 38.89% | |||
| Total Operating Expenses | 3.77% | 10.94% | |||
| Operating Income | 26.12% | 54.37% | |||
| Income Before Tax | 55.93% | 3.47% | |||
| Income Tax Expenses | 42.74% | -10.39% | |||
| Earnings from Continuing Operations | 61.56% | 10.77% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -103.45% | 6.45% | |||
| Net Income | 60.52% | 11.28% | |||
| EBIT | 26.12% | 54.37% | |||
| EBITDA | 12.76% | 27.19% | |||
| EPS Basic | 63.15% | 13.77% | |||
| Normalized Basic EPS | 30.92% | 52.77% | |||
| EPS Diluted | 56.44% | 12.64% | |||
| Normalized Diluted EPS | 29.85% | 51.40% | |||
| Average Basic Shares Outstanding | -1.61% | -2.22% | |||
| Average Diluted Shares Outstanding | -0.84% | -1.43% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||